Analysis of Proteomics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Projected to expand at a CAGR of 16.6%, the global proteomics market is expected to swiftly increase from a valuation of US$ 41.9 million in 2024 to US$ 194.6 million by the end of 2034.
The market is benefiting as the understanding of protein cells is emerging as an important field of study in healthcare. Proteomics involves the study of interactions, functions, composition, and structures of proteins and their cellular activities. Proteomics provides a deeper understanding of the structure and function of an organism than genomics.
Proteins are the fundamental cells, and to prevent the spread of diseases, doctors must understand the functionality of these protein cells. After the COVID-19 pandemic, governments across the world have begun investing in proteomics to ensure readiness for any medical emergencies.
Primary purpose of proteomics is to detect protein expression patterns at a given time in response to a specific stimulus and determine functional protein networks that exist at the level of the cell, or whole organism. The proteomics market is projected to grow at a significant rate as scientists understand the human body more vividly and help prevent the spread of any disease on a large scale.
Key Market Growth Drivers
| Report Attribute | Detail |
|---|---|
| Proteomics Market Size (2024E) | US$ 41.9 Million |
| Forecasted Market Value (2034F) | US$ 194.6 Million |
| Global Market Growth Rate (2024 to 2034) | 16.6% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 17% CAGR |
| China Market Value (2034F) | US$ 16 Million |
| North America Market Share (2024E) | 36.8% |
| East Asia Market Share (2034F) | 20% |
| Key Companies Profiled | Agilent Technologies; Bruker; Thermo Fisher Scientific; Merck KGaA; GE HealthCare; PerkinElmer; Biognosys AG; Charles River Laboratories; Horiba; Danaher Corporation; Carpicon Proteomics Inc.; Luminex Corporation; Waters Corporation; Bio-Rad Laboratories; Promega Corporation. |
“Growing Demand for Personalized Medicine and Rising Burden of Genetic Disorders”
Growth of the market is being propelled by the demand for personalized medicine, technological advancements, and innovation, alongside increased funding opportunities from both public and private sectors. Given the rapid expansion of the pharmaceutical and biopharmaceutical fields, the demand for proteomics has increased. The global market is projected to exhibit significant expansion in the coming decades due to a heightened need for customized medication and the rising costs associated with genetic illnesses.
Another factor projected to fuel market growth is the rising prevalence of chronic diseases such as cancer, cardiovascular diseases (CVDs), respiratory diseases, CKD, and other ailments.
“Focus on Refining Sample Preparation and Fractionation Techniques”
Modern advancements in technology have revolutionized proteomics, enhancing sensitivity and resolution, enabling high throughput and multiplexed analysis, refining sample preparation and fractionation techniques, facilitating mass spectrometry-based imaging, and providing advanced data analysis tools. These advancements have deepened the understanding of the proteome, accelerating biomarker discovery, personalized medicine, and drug development.
Recent technological breakthroughs have broadened the scope of proteomics research, allowing for a more comprehensive exploration of proteins across various biological contexts. Progress in protein function, disease mechanisms, drug discovery, and personalized medicine has been the driving force behind this growth.
“Governmental Backing for Proteomics Research and Applications”
Advancements in proteomic technologies and methodologies in the Asia Pacific region are driving market growth. Researchers in this region utilize advanced techniques such as mass spectrometry, protein profiling, and protein interaction analysis to investigate complex biological systems.
Availability of sophisticated proteomics platforms and instruments has stimulated the expansion of proteomics research and applications. Governments in the Asia Pacific region are actively supporting scientific research and innovation, including in proteomics.
Initiatives such as research grants, funding programs, and regulatory frameworks bolster proteomics research and its applications. This governmental backing has cultivated a conducive environment for proteomics development in the region. With competition intensifying in developed countries, market players are redirecting their attention to developing countries for stability.
“Lack of Data Management Capabilities and High Cost of Instruments”
Proteomics research is used to discover new drugs, vaccines, and diagnostic targets, as well as characterize protein-based products, conduct toxicology studies, and identify surrogate markers of activity in clinical research to understand drug mechanisms. Protein analytics can be costly due to the need for various platforms, instruments, documentation systems, software, and databases in the lab.
Proteomics experiments require specialized expertise for sample preparation, data analysis, and interpretation. This expertise can be difficult and expensive to obtain, especially for smaller organizations. High instrument costs can limit market growth. Limited adoption due to cost constraints may slow market expansion.
As proteome analysis deepens, the volume of data generated is projected to increase. Managing and processing proteomics data requires specialized expertise, resources, and infrastructure. Addressing these challenges is critical to the advancement of proteomics research.
The market in Japan is projected to expand at a CAGR of 18.3% from 2024 to 2034, and the country is projected to occupy a proteomics market share of 52.6% by 2034 in the East Asia region.
“High Demand for High-quality Research Equipment”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 13 Million |
| Growth Rate (2024 to 2034) | 16.6% CAGR |
| Projected Value (2034F) | US$ 61 Million |
Advancement of proteomics research, the demand for high-quality research equipment to ensure data reproducibility, and the emphasis on personalized treatment development have all contributed to the prominence of the field in the United States. Collaborations and agreements among major players in the country are also fueling market growth.
“Government Support for Research in Genomics and Proteomics”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 3 Million |
| Growth Rate (2024 to 2034) | 18.9% CAGR |
| Projected Value (2034F) | US$ 16 Million |
During the forecast period, the Chinese market is projected to grow at a significant pace due to increased government initiatives to support research and development in genomics, bioinformatics, and proteomics. The government has become cautious after the COVID-19 pandemic to make sure no such medical emergencies occur in the country again, thus driving proteomics market growth.
By end user, the research and academics segment is estimated to hold a market share of 51.5% in 2024.
“Ease of Use Associated with Reagents & Kits”
| Attribute | Reagents & Kits |
|---|---|
| Segment Value (2024E) | US$ 21.6 Million |
| Growth Rate (2024 to 2034) | 16.7% CAGR |
| Projected Value (2034F) | US$ 101.4 Million |
Reagents and kits are very helpful in drug testing, as they are simple to use and involve easy procedures. This facilitates the quick formulation of solutions. The segment accounts for more than half of overall product sales and will continue to do so over the next ten years.
“Microarray Instruments Facilitating Enhanced Replication Capabilities”
| Attribute | Microarray Instruments |
|---|---|
| Segment Value (2024E) | US$ 11.4 Million |
| Growth Rate (2024 to 2034) | 16.6% CAGR |
| Projected Value (2034F) | US$ 52.9 Million |
Microarray instruments facilitate increased replication and provide wider diversity in environmental samples, thus boosting their widespread use in proteomics research. They facilitate easy identification of gene sets linked to metastasis or response to treatment.
Key players in the proteomics market are incorporating innovative technologies into their product portfolio. To enhance their sales and expand their market share, companies are pursuing strategies such as collaborations and partnerships and expanding their presence in research into mycoprotein products and plant protein ingredients.
Fact.MR provides detailed information about the price points of key players in the proteomics market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
How much is the proteomics market worth in 2024?
The global proteomics market is estimated at US$ 41.9 million in 2024.
What is the future of the proteomics market?
The market for proteomics is projected to reach US$ 194.6 million by 2034.
At what rate is the global market forecasted to expand?
Global demand for proteomics is projected to rise at a CAGR of 16.6%.
How is the market anticipated to perform in Japan?
The market in Japan is forecasted to reach US$ 20 million by 2034-end.
At what rate is the market forecasted to expand in Canada?
The proteomics market in Canada is projected to rise at 17% CAGR through 2034.
Who are the leading companies involved in proteomics?
Leading market players are Agilent Technologies, Bruker, and Horiba.
What is the projected use of spectroscopy for 2034?
Spectroscopy usage is projected to reach a market value of US$ 17.3 million by the end of 2034.
Proteomics Market